SFCM
PCVX icon

Seven Fleet Capital Management’s Vaxcyte PCVX Stock Holding History

Seven Fleet Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Sell
29,800
-78,650
-73% -$4.27M 0.29% 44
2026
Q1 		$6.3M Buy
108,450
+83,085
+328% +$4.51M 1.98% 9
2025
Q4 		$1.17M Buy
+25,365
New +$1.13M 0.79% 23

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Seven Fleet Capital Management's PCVX Position: Q2 2026 in Review

Seven Fleet Capital Management reduced its Vaxcyte (PCVX) stake by 73% in Q2 2026, selling an estimated $4.27M and leaving 29,800 shares worth $1.78M. The position accounts for 0.29% of the portfolio, ranked #44.

Seven Fleet Capital Management first reported a position in PCVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.3M in Q1 2026. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Seven Fleet Capital Management held 29,800 shares of Vaxcyte worth $1.78M as of Q2 2026.
  • Seven Fleet Capital Management sold 78,650 Vaxcyte shares in Q2 2026, an estimated $4.27M.
  • Vaxcyte made up 0.29% of Seven Fleet Capital Management's portfolio in Q2 2026, its #44 holding.
  • Seven Fleet Capital Management first reported a position in Vaxcyte in Q4 2025 and has held it in 3 quarters since.
  • Seven Fleet Capital Management's Vaxcyte position peaked at $6.3M in Q1 2026.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.